Has Emily Speeg received payments from drug or device companies?

Yes. Drug and device makers reported $1,884 in general payments to Emily Speeg across 114 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Emily Speeg did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Emily Speeg come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Emily Speeg

Dermatology · Lafayette, LANPI 1720241177

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.2% of the total across 114 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Novartis at 51.9% of the total. Reporting peaked in 2021 at $512 and has fallen 79.2% since, to $107 in 2025. That places this record below the midpoint for dermatology clinicians in LA, where the typical reported total is $5,293.

$1,884in general payments, 2019–2025

Across 114 payments — averaging $16.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$978
AbbVie$225
Pfizer$118
Lilly USA, LLC$107
Johnson & Johnson$77
Sun Pharmaceutical Industries Inc.$66
plus $314 from 11 others

What the payments were for

Food & beverage$1,86999%
Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	64	$978
AbbVie(2 entities)	15	$225
Pfizer	7	$118
Lilly USA, LLC	1	$107
Johnson & Johnson	5	$77
Sun Pharmaceutical Industries Inc.	4	$66
ANI Pharmaceuticals, Inc.	2	$45
Amgen	2	$35
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$34
VYNE Pharmaceuticals Inc.	2	$34
LEO Pharma Inc.	2	$33
Regeneron Healthcare Solutions, Inc.	2	$30
Galderma Laboratories, L.p.	2	$26
Incyte Corporation	1	$21
Medimetriks Pharmaceuticals, Inc.	1	$20
Astellas Pharma US Inc	1	$19
UCB, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

EBGLYSS$107

How this compares

$1,884 in reported general payments places this provider in the 25th percentile of 189 dermatology providers in Louisiana.

See all dermatology providers in Louisiana →

Other dermatology in Lafayette

Blair BuddenLafayette$329K
Frankie RholdonLafayette$227K
Daniel DupreeLafayette$30K
Chris HubbellLafayette$20K
Lien Kim DrewLafayette$17K
Kristy KennedyLafayette$13K
David PowellLafayette$10K
Tyson MeauxLafayette$9K
Katherine HolcombMetairie$411K
William ClaiborneNew Orleans$374K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →